Protagonist Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PTGX and other ETFs, options, and stocks.

About PTGX

Protagonist Therapeutics, Inc. a clinical-stage biopharmaceutical company, which engages in discovering and developing peptide-based therapeutic drugs to address unmet medical needs. Its product pipeline includes PTG-300, PTG-200, and PN-943.

CEO

Dinesh V. Patel

CEODinesh V. Patel

Employees

126

Employees126

Headquarters

Newark, California

HeadquartersNewark, California

Founded

2006

Founded2006

Employees

126

Employees126

PTGX Key Statistics

Market cap

2.83B

Market cap2.83B

Price-Earnings ratio

10.84

Price-Earnings ratio10.84

Dividend yield

—

Dividend yield—

Average volume

1.32M

Average volume1.32M

High today

$47.35

High today$47.35

Low today

$45.73

Low today$45.73

Open price

$46.89

Open price$46.89

Volume

1.41M

Volume1.41M

52 Week high

$60.60

52 Week high$60.60

52 Week low

$24.22

52 Week low$24.22

PTGX News

TipRanks 2h

CFO Cashes In: Protagonist Therapeutics Stock Sale Shakes Market!

New insider activity at Protagonist Therapeutics ( (PTGX) ) has taken place on April 24, 2025. CFO Asif Ali recently sold 1,756 shares of Protagonist Therapeut...

Analyst ratings

91%

of 11 ratings

Buy

90.9%

Hold

9.1%

Sell